Anavex Life Sciences Corp (AVXL)

[Anshu2]

There is no approval mechanism (other than AA) which is subject to an additional trial. AA is a very unique concept. It requires a surrogate/biological market or an intermediate end-point --- neither of which may be applicable to AVXL's drug.

Point: Either AVXL's ad drug would be approval or not. There is nothing like approval conditioned on an additional trial (except for AA, which is very likely not applicable here).